"The drug for the treatment of leukemia and other oncological diseases" Vincristine "will be admitted to public procurement without restrictions," - said in a statement on the website of the Cabinet.
"Vincristine" is included in the list of vital and essential medicines (VED).
Medicines from this list, which are manufactured abroad, do not participate in auctions if there are analogues from at least two manufacturers from the EAEU.
In the case of this drug, such a restriction interfered with effective treatment, the press service noted.
So, changing the medication could lead to a deterioration in the condition of a patient with a rapidly progressing disease.
At the end of August, the rules for subsidizing the import of the drug "Oncaspar" from France to Russia for children with leukemia were approved.